Wellington Management Group LLP Ultragenyx Pharmaceutical Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 4,165,424 shares of RARE stock, worth $184 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,165,424

Previous 4,556,167 8.58%

Holding current value

$184 Million

Previous $187 Million 23.57%

% of portfolio

0.04%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.21 - $59.36 $15.7 Million - $23.2 Million	-390,743 Reduced 8.58%	4,165,424 $231 Million
Q2 2024 Aug 13, 2024	BUY	$37.42 - $51.61 $17.1 Million - $23.6 Million	458,192 Added 11.18%	4,556,167 $187 Million
Q1 2024 May 15, 2024	BUY	$43.02 - $53.69 $176 Million - $220 Million	4,097,975 New	4,097,975 $191 Million
Q4 2023 Feb 12, 2024	BUY	$31.73 - $49.19 $140 Million - $217 Million	4,415,029 New	4,415,029 $211 Million
Q3 2023 Nov 14, 2023	BUY	$34.92 - $46.66 $641,096 - $856,630	18,359 Added 0.35%	5,195,880 $185 Million
Q2 2023 Aug 14, 2023	BUY	$37.35 - $52.15 $2.85 Million - $3.98 Million	76,374 Added 1.5%	5,177,521 $239 Million
Q1 2023 May 12, 2023	SELL	$36.99 - $48.71 $3.76 Million - $4.95 Million	-101,537 Reduced 1.95%	5,101,147 $205 Million
Q4 2022 Feb 13, 2023	SELL	$33.72 - $46.33 $28.4 Million - $39.1 Million	-843,354 Reduced 13.95%	5,202,684 $241 Million
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $65.2 Million - $108 Million	1,631,598 Added 36.96%	6,046,038 $250 Million
Q2 2022 Aug 15, 2022	BUY	$45.8 - $85.4 $47.8 Million - $89.2 Million	1,044,195 Added 30.98%	4,414,440 $263 Million
Q1 2022 May 16, 2022	BUY	$62.2 - $84.4 $30.7 Million - $41.6 Million	492,842 Added 17.13%	3,370,245 $245 Million
Q4 2021 Feb 11, 2022	BUY	$73.71 - $87.86 $27.2 Million - $32.4 Million	369,128 Added 14.72%	2,877,403 $242 Million
Q3 2021 Nov 15, 2021	BUY	$77.92 - $102.4 $164 Million - $216 Million	2,108,704 Added 527.74%	2,508,275 $226 Million
Q2 2021 Aug 16, 2021	SELL	$92.19 - $115.71 $22.1 Million - $27.7 Million	-239,691 Reduced 37.49%	399,571 $38.1 Million
Q1 2021 May 17, 2021	SELL	$106.9 - $167.73 $2.99 Million - $4.68 Million	-27,925 Reduced 4.19%	639,262 $72.8 Million
Q4 2020 Feb 12, 2021	SELL	$84.4 - $177.39 $7.3 Million - $15.3 Million	-86,437 Reduced 11.47%	667,187 $92.4 Million
Q3 2020 Nov 16, 2020	BUY	$72.98 - $90.0 $10.2 Million - $12.6 Million	140,038 Added 22.82%	753,624 $61.9 Million
Q2 2020 Aug 14, 2020	SELL	$46.91 - $78.22 $10.5 Million - $17.4 Million	-222,971 Reduced 26.65%	613,586 $48 Million
Q1 2020 May 14, 2020	SELL	$33.8 - $62.9 $15.1 Million - $28.2 Million	-447,553 Reduced 34.85%	836,557 $37.2 Million
Q4 2019 Feb 11, 2020	BUY	$36.08 - $45.83 $46.3 Million - $58.9 Million	1,284,110 New	1,284,110 $54.8 Million

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.6M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.1B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Ultragenyx Pharmaceutical Inc. Transaction History